TrialJournal of diabetes investigation2023

Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of two randomized, placebo-controlled trials.

Katsuhiko Hagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.